{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:51:26Z","timestamp":1753890686175,"version":"3.41.2"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00257","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T13:58:35Z","timestamp":1587477515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia"],"prefix":"10.3389","volume":"8","author":[{"given":"Sara","family":"Donzelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Farneti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Ganci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Strano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Sanguineti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Blandino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.18632\/oncotarget.14253","article-title":"MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.","volume":"8","author":"Arantes","year":"2017","journal-title":"Oncotarget"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","article-title":"Mediators of cachexia in cancer patients.","volume":"66","author":"Argiles","year":"2019","journal-title":"Nutrition"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.biocel.2013.06.021","article-title":"Muscle wasting: the gut microbiota as a new therapeutic target?","volume":"45","author":"Bindels","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1016\/j.febslet.2014.03.033","article-title":"Tumor suppressor microRNAs: a novel non-coding alliance against cancer.","volume":"588","author":"Blandino","year":"2014","journal-title":"FEBS Lett."},{"key":"B5","first-page":"114","article-title":"How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market.","volume":"30","author":"Bonneau","year":"2019","journal-title":"EJIFCC"},{"key":"B6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers.","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1158\/0008-5472.can-13-2817","article-title":"Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle.","volume":"74","author":"Chen","year":"2014","journal-title":"Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids\u2013the mix of hormones and biomarkers.","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge.","volume":"10","author":"Cui","year":"2019","journal-title":"Fron. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/jcmm.12358","article-title":"MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.","volume":"18","author":"Cui","year":"2014","journal-title":"J. Cell Mol. Med."},{"key":"B11","first-page":"721s","article-title":"Pathophysiology of cancer cachexia: current understanding and areas for future research.","volume":"42","author":"DeWys","year":"1982","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","article-title":"miRNA profiling of cancer.","volume":"23","author":"Di Leva","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B13","doi-asserted-by":"crossref","first-page":"35183","DOI":"10.18632\/oncotarget.5930","article-title":"Epigenetic silencing of miR-145-5p contributes to brain metastasis.","volume":"6","author":"Donzelli","year":"2015","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus.","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3892\/br.2016.747","article-title":"Emerging role of microRNA-21 in cancer.","volume":"5","author":"Feng","year":"2016","journal-title":"Biomed. Rep."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.20944\/preprints201909.0004.v1","author":"Fernandez","year":"2019","journal-title":"MicroRNA-mRNA co-Sequencing Identifies Transcriptional and Post-transcriptional Regulatory Networks Underlying muscle Wasting in Cancer Cachexia."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3390\/cancers7040904","article-title":"Oncogenic MicroRNAs: key players in malignant transformation.","volume":"7","author":"Frixa","year":"2015","journal-title":"Cancers"},{"key":"B19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/carcin\/bgx134","article-title":"MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration.","volume":"39","author":"Frixa","year":"2018","journal-title":"Carcinogenesis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals.","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.rpor.2015.03.001","article-title":"Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy.","volume":"20","author":"Gorenc","year":"2015","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125094","article-title":"Muscle releases alpha-sarcoglycan positive extracellular vesicles carrying mirnas in the bloodstream.","volume":"10","author":"Guescini","year":"2015","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.440","article-title":"Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.","volume":"8","author":"Hamam","year":"2017","journal-title":"Cell Death Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1074\/jbc.274.2.787","article-title":"Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.","volume":"274","author":"Han","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research.","volume":"10","author":"Hanna","year":"2019","journal-title":"Front. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1073\/pnas.1402714111","article-title":"Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.","volume":"111","author":"He","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2015.12.013","article-title":"Muscle-specific microRNAs in skeletal muscle development.","volume":"410","author":"Horak","year":"2016","journal-title":"Dev. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1200\/jco.2009.24.9342","article-title":"Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.","volume":"28","author":"Hu","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B29","first-page":"1461","article-title":"Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention.","volume":"6","author":"Izzotti","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"B30","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","article-title":"Muscle wasting in cancer.","volume":"45","author":"Johns","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2013.07.004","article-title":"MicroRNAs in skeletal muscle biology and exercise adaptation.","volume":"64","author":"Kirby","year":"2013","journal-title":"Free Radic Biol. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1016\/j.ejca.2013.06.002","article-title":"Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.","volume":"49","author":"Koberle","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1349-7006.2010.01650.x","article-title":"Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.","volume":"101","author":"Kosaka","year":"2010","journal-title":"Cancer Sci."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00173","article-title":"Trash or Treasure: extracellular microRNAs and cell-to-cell communication.","volume":"4","author":"Kosaka","year":"2013","journal-title":"Front. Genet."},{"key":"B35","doi-asserted-by":"crossref","first-page":"E267","DOI":"10.1152\/ajpendo.00249.2013","article-title":"MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia.","volume":"306","author":"Kulyte","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/hed.24672","article-title":"Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.","volume":"39","author":"Kwon","year":"2017","journal-title":"Head Neck"},{"key":"B37","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/10245332.2017.1292204","article-title":"Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia.","volume":"22","author":"Labib","year":"2017","journal-title":"Hematology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physiolgenomics.00006.2017","article-title":"Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size.","volume":"49","author":"Lee","year":"2017","journal-title":"Physiol. Genomics"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1186\/s41544-019-0025-x","article-title":"Exosomal miRNA: an alternative mediator of cell-to-cell communication.","volume":"1","author":"Li","year":"2019","journal-title":"ExRNA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3892\/or.2014.3029","article-title":"Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.","volume":"31","author":"Li","year":"2014","journal-title":"Oncol. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer.","volume":"15","author":"Lin","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1002\/1878-0261.12561","article-title":"miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.","volume":"13","author":"Lindholm","year":"2019","journal-title":"Mol. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers.","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection.","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S. A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jcsm.12168","article-title":"Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia.","volume":"8","author":"Narasimhan","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/jcsm.12403","article-title":"Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients.","volume":"10","author":"Okugawa","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B47","first-page":"1555","article-title":"Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.","volume":"39","author":"Okugawa","year":"2018","journal-title":"Oncol. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/bjc.2016.3","article-title":"Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia.","volume":"114","author":"Penafuerte","year":"2016","journal-title":"Br. J. Cancer"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling.","volume":"7","author":"Pettersen","year":"2017","journal-title":"Sci. Rep."},{"key":"B50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ddr.21257","article-title":"The role of miR-21 in cancer.","volume":"76","author":"Pfeffer","year":"2015","journal-title":"Drug Dev. Res."},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090294","article-title":"miRNA-130a significantly improves accuracy of SGA nutritional assessment tool in prediction of malnutrition and cachexia in radiotherapy-treated head and neck cancer patients.","volume":"10","author":"Powrozek","year":"2018","journal-title":"Cancers"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2017.22","article-title":"Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.","volume":"3","author":"Pulito","year":"2017","journal-title":"Cell Discov."},{"key":"B53","article-title":"Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours.","volume":"2","author":"Rakheja","year":"2014","journal-title":"Nat. Commun."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020459","article-title":"Epigenetics and MicroRNAs in Cancer.","volume":"19","author":"Ramassone","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-319-72790-5_6","article-title":"Skeletal muscle microRNAs: roles in differentiation, disease and exercise","author":"Sj\u00f6gren","year":"2017","journal-title":"Hormones, Metabolism and the Benefits of Exercise"},{"key":"B56","doi-asserted-by":"crossref","first-page":"21909","DOI":"10.1074\/jbc.M114.561845","article-title":"Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions.","volume":"289","author":"Soares","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-5887-7","article-title":"Refinement of breast cancer molecular classification by miRNA expression profiles.","volume":"20","author":"Sokilde","year":"2019","journal-title":"BMC Genomics"},{"key":"B58","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/jcsm.12384","article-title":"MicroRNAs in muscle wasting.","volume":"9","author":"Suzuki","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B59","first-page":"3097","article-title":"Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.","volume":"8","author":"Tian","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways.","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-62703-748-8_3","article-title":"The role of microRNAs in human diseases.","volume":"1107","author":"Tufekci","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/jcsm.12512","article-title":"Identification of microRNAs in skeletal muscle associated with lung cancer cachexia.","volume":"11","author":"Van de Worp","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B63","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/jcsm.12506","article-title":"Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology.","volume":"11","author":"Van Westering","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1878-0261.12468","article-title":"The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment.","volume":"13","author":"Verduci","year":"2019","journal-title":"Mol. Oncol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse.","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s13277-014-2803-2","article-title":"Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.","volume":"36","author":"Wu","year":"2015","journal-title":"Tumour. Biol."},{"key":"B67","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1261\/rna.1034808","article-title":"MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.","volume":"14","author":"Yan","year":"2008","journal-title":"RNA"},{"key":"B68","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2147\/CMAR.S191696","article-title":"Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.","volume":"11","author":"Ye","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"B69","first-page":"4194","article-title":"Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-12-155","article-title":"NF-kappaB-modulated miR-130a targets TNF-alpha in cervical cancer cells.","volume":"12","author":"Zhang","year":"2014","journal-title":"J. Transl. Med."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102413","article-title":"Prognostic value of miR-21 in various cancers: an updating meta-analysis.","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/cr.2008.24","article-title":"MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.","volume":"18","author":"Zhu","year":"2008","journal-title":"Cell Res."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00257\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T01:19:11Z","timestamp":1615339151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00257\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":72,"alternative-id":["10.3389\/fcell.2020.00257"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00257","relation":{},"ISSN":["2296-634X"],"issn-type":[{"type":"electronic","value":"2296-634X"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"article-number":"257"}}